Preference for Sayana® Press versus intramuscular Depo-Provera among HIV-positive women in Rakai, Uganda: A randomized crossover trial

Contraception

Volumn 89, Issue 5, 2014, Pages 385-395

  Polis, Chelsea B ^a,b   Nakigozi, Gertrude F ^c   Nakawooya, Hadijja ^c   Mondo, George ^c   Makumbi, Fredrick ^d   Gray, Ronald H ^b  

^a UNITED STATES AGENCY FOR INTERNATIONAL DEVELOPMENT   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c RAKAI HEALTH SCIENCES PROGRAM   (Uganda)

^d MAKERERE UNIVERSITY COLLEGE OF HEALTH SCIENCES   (Uganda)

Author keywords

Acceptability; Contraception; Injectable; Intramuscular; Subcutaneous

Indexed keywords

MEDROXYPROGESTERONE ACETATE; SAYANA PRESS; UNCLASSIFIED DRUG; CONTRACEPTIVE AGENT;

ADULT; ARTICLE; CONTRACEPTION; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG PREFERENCE; EXPERIENCE; FATIGUE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INJECTION SITE PAIN; MAJOR CLINICAL STUDY; MENORRHAGIA; MENSTRUAL IRREGULARITY; PATIENT PARTICIPATION; PATIENT SATISFACTION; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SKIN IRRITATION; SPOTTING; UGANDA; UNPLANNED PREGNANCY; ADOLESCENT; COMPARATIVE STUDY; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAMUSCULAR DRUG ADMINISTRATION; MIDDLE AGED; PATIENT PREFERENCE; STATISTICS AND NUMERICAL DATA; SUBCUTANEOUS DRUG ADMINISTRATION; YOUNG ADULT;

ADOLESCENT; ADULT; CONTRACEPTIVE AGENTS, FEMALE; CROSS-OVER STUDIES; FEMALE; HIV INFECTIONS; HUMANS; INJECTIONS, INTRAMUSCULAR; INJECTIONS, SUBCUTANEOUS; MEDROXYPROGESTERONE ACETATE; MIDDLE AGED; PATIENT PREFERENCE; UGANDA; YOUNG ADULT;

EID: 84899936459     PISSN: 00107824     EISSN: 18790518     Source Type: Journal    
DOI: 10.1016/j.contraception.2013.11.008     Document Type: Article

References (23)

1. United Nations World contraceptive use 2011 2011
2. Uganda Bureau of Statistics (UBOS), ICF International Uganda demographic and health survey 2011 2011 ICF International Inc Kampala, Uganda and Calverton, Maryland 2012
3. J. Jain, A.J. Jakimiuk, F.R. Bode, D. Ross, and A.M. Kaunitz Contraceptive efficacy and safety of DMPA-SC Contraception 70 2004 269 275
4. A.M. Kaunitz, P.D. Darney, D. Ross, K.D. Wolter, and L. Speroff Subcutaneous vs. intramuscular DMPA: a 2-year randomized study of contraceptive efficacy and bone mineral density Contraception 80 2009 7 17
5. M.A. Simon, and L.P. Shulman Subcutaneous versus intramuscular depot methoxyprogesterone acetate: a comparative review Womens Health (Lond Engl) 2 2006 191 197
6. L. Bahamondes, N.M. Marchi, and Cristofoletti M. de Lourdes et al. Uniject as a delivery system for the once-a-month injectable contraceptive Cyclofem in Brazil Contraception 53 1996 115 119
7. A. Sutanto, I.M. Suarnawa, C.M. Nelson, T. Stewart, and T.I. Soewarso Home delivery of heat-stable vaccines in Indonesia: outreach immunization with a prefilled, single-use injection device Bull World Health Organ 77 1999 119 126
8. V.D. Tsu, A. Sutanto, K. Vaidya, P. Coffey, and A. Widjaya Oxytocin in prefilled Uniject injection devices for managing third-stage labor in Indonesia Int J Gynaecol Obstet 83 2003 103 111
9. S.J. Phillips, K.M. Curtis, and C.B. Polis Effect of hormonal contraceptive methods on HIV disease progression: a systematic review Aids 27 2013 787 794
10. C.B. Polis, M.J. Wawer, and N. Kiwanuka et al. Effect of hormonal contraceptive use on HIV progression in female HIV seroconverters in Rakai, Uganda Aids 24 2010 1937 1944
11. C.B. Polis, S.J. Phillips, and K.M. Curtis Hormonal contraceptive use and female-to-male HIV transmission: a systematic review of the epidemiologic evidence Aids 27 2013 493 505
12. WHO. Hormonal contraception and HIV: technical statement. Geneva, Switzerland 2012.
13. F. Laher, C.S. Todd, and M.A. Stibich et al. Role of menstruation in contraceptive choice among HIV-infected women in Soweto, South Africa Contraception 81 2010 547 551
14. H. Brahmbhatt, F. Makumbi, and T. Lutalo et al. Longitudinal study of correlates of modern contraceptive use and impact of HIV care programmes among HIV concordant and serodiscordant couples in Rakai, Uganda J Fam Plann Reprod Health Care 2013 [ePub ahead of print]. http://dx.doi.org/10.1136/jfprhc-2013- 100593
15. J.H. Chu, S.J. Gange, and K. Anastos et al. Hormonal contraceptive use and the effectiveness of highly active antiretroviral therapy Am J Epidemiol 161 2005 881 890
16. F.T. Aweeka, S.L. Rosenkranz, and Y. Segal et al. The impact of sex and contraceptive therapy on the plasma and intracellular pharmacokinetics of zidovudine Aids 20 2006 1833 1841
17. S.E. Cohn, J.G. Park, and D.H. Watts et al. Depo-medroxyprogesterone in women on antiretroviral therapy: effective contraception and lack of clinically significant interactions Clin Pharmacol Ther 81 2007 222 227
18. D.H. Watts, J.G. Park, and S.E. Cohn et al. Safety and tolerability of depot medroxyprogesterone acetate among HIV-infected women on antiretroviral therapy: ACTG A5093 Contraception 77 2008 84 90
19. K. Nanda, E. Amaral, M. Hays, M.A. Viscola, N. Mehta, and L. Bahamondes Pharmacokinetic interactions between depot medroxyprogesterone acetate and combination antiretroviral therapy Fertil Steril 90 2008 965 971
20. R.L. Williams, D.J. Hensel, and J.D. Fortenberry Self-administration of subcutaneous depot medroxyprogesterone acetate by adolescent women Contraception 88 3 2013 401 407
21. G. Zou A modified Poisson regression approach to prospective studies with binary data Am J Epidemiol 159 2004 702 706
22. V. Halpern, S. Combes, D. Weiner, and D. Archer Pharmacokinetics of subcutaneous depot medroxyprogesterone acetate injected in the upper arm Contraception 86 2012 315
23. J.A. Robinson, R. Jamshidi, and A.E. Burke Contraception for the HIV-positive woman: a review of interactions between hormonal contraception and antiretroviral therapy Infect Dis Obstet Gynecol 2012 2012 890160